MagnaCare, a New York-based health plan management company, announced its partnership with Bethesda, MD-based Telcare, maker of the BGM wireless-enabled blood glucose meter.

The Telcare BGM automatically transmits readings to an FDA-cleared, privacy-secured online database that can be accessed via web browser or smartphone apps by patients, physicians, caregivers or family members, as authorized by the patient. The device transmits real-time access to readings, provides feedback, and enables physicians and caregivers to intervene when blood glucose levels reach dangerous levels.

Through this partnership, MagnaCare clients will be among the first in the country to receive the Telcare BGM devices, which were launched this month at the Consumer Electronics Show in Las Vegas.

“The biggest challenge in the treatment of diabetes is compliance; a 10% improvement in glucose control can reduce the incidence of complications by 37%,” says Telcare CEO and Vice Chairman Jonathan C. Javitt. “BGM was developed to eliminate noncompliance and inconsistency in tracking numbers. This technology is truly impactful in terms of connecting provider to patient.”